Aug 11, 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
May 28, 2020
global market for viral vector and plasmid manufacturing is predicted to grow at a CAGR of 16.28% over the forecast period of 2020-2030
May 27, 2020
OncoSec Strengthens IP Portfolio with Three New Patents Covering TAVO(TM) and Its Electroporation Gene Delivery System
Apr 28, 2020
The Global Transfection Reagents & Equipment Market is expected to grow from USD 913.84 Million in 2018 to USD 1,529.05 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.63%
Apr 23, 2020
FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE(TM) To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing
Apr 22, 2020
REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
Apr 21, 2020
OncoSec Presents Pre-Clinical Data from Its Visceral Lesion Applicator (VLA) and APOLLO Feasibility Study Demonstrating TAVO(TM) Can Be Safely Delivered and Electroporated in Liver at the Online Society of Interventional Radiology Annual Meeting
Apr 01, 2020
Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!
Mar 30, 2020
Delphi Genetics More Than Triples Its Production Capacity and Receives GMP Certification
Mar 26, 2020
Global Viral Vector and Plasmid DNA Testing Services Market to Surpass US$ 565.3 Million by 2027, says CMI
Mar 17, 2020
PharmaJet Received Multi-Year, Multi-Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices
Mar 11, 2020
Plasmid DNA Manufacturing Market to Reach Valuation US$ 300 Mn by 2026
Mar 10, 2020
Global Transfection Technologies Market Analysis, 2020-2025 - Increasing R&D in the Field of Cell-Based Therapies
Feb 24, 2020
Study Advances Development of Gene Therapy for x-Linked Retinitis Pigmentosa
Feb 24, 2020
Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV)
Feb 12, 2020
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
Feb 11, 2020
Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Feb 06, 2020
The global gene therapy market was valued at $393.35 million in 2018, and is estimated to reach $6,205.85 million by 2026, registering a CAGR of 34.8% from 2019 to 2026
Feb 04, 2020
Columbus Children's Foundation receives commitment to accelerate production of curative treatments for children with ultra-rare genetic diseases
Feb 03, 2020
OncoSec's Visceral Lesion Applicator (VLA) Electroporation Device Demonstrates Targeted Entry and Deployment in Both Lung and Liver in Data Presented at the Society of Interventional Oncology Annual Meeting